Wearable cardiac monitor developer iRhythm disclosed its third subpoena in more than two years from federal investigators. The news raised some questions from analysts, who were otherwise positive about iRhythm’s first-quarter earnings report yesterday evening. San Francisco–based iRhythm said that on April 4, it received a subpoena duces tecum from the U.S. Department of Justice […]
iRhythm Technologies Inc.
Real-world study backs iRhythm Zio XT
iRhythm Technologies (Nasdaq:IRTC) today announced findings supporting its Zio XT wearable heart monitoring technology. San Francisco-based iRhythm presented multiple new studies at the American College of Cardiology’s Annual Scientific Session Together With the World Congress of Cardiology (ACC.23/WCC). The Camelot study compared effectiveness of ambulatory monitors for arrhythmia diagnosis. It demonstrated that long-term continuous monitoring […]
iRhythm sees years of sustainable growth
Wearable cardiac monitor developer iRhythm (NASDAQ:IRTC) saw its stock shoot up today, a day after reporting positive Q4 2022 news. IRTC shares were up more than 10% at $97.26 apiece by midday trading today. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was up more than 8%. San Francisco–based […]
iRhythm wants to be a $1 billion a year company in 5 years
iRhythm Technologies (Nasdaq:IRTC) officials think their company’s wearable heart monitoring tech could serve millions more patients, tripling company revenue to more than $1 billion by 2027. That was a big takeaway from the company’s 2022 Analyst & Investor Day news release today. “Our technology platform is well suited to meet the needs of an evolving […]
iRhythm Technologies stock jumps on Q2 earnings beat
iRhythm Technologies (Nasdaq:IRTC) posted second-quarter results that beat the consensus forecast on Wall Street. Yesterday evening, the San Francisco–based developer of the Zio ambulatory cardiac monitor reported a loss of $23.9 million, or $0.80 per share, on sales of $102.1 million for the quarter ended June 30, 2022. Revenue was up 25.6% year-over-year, primarily driven […]
Studies show that iRhythm’s Zio detects AFib early, prevents hospital admissions
iRhythm Technologies (Nasdaq:IRTC) announced results of multiple studies supporting the use of its Zio technology in detecting AFib. San Francisco-based iRhythm presented the results of three clinical research studies at The American College of Cardiology’s 71st Annual Scientific Session & Expo. According to a news release, the studies further validate Zio as an option for […]
Former CEO Kevin King to retire from iRhythm’s board of directors
iRhythm Technologies (Nasdaq:IRTC) announced today that Kevin King will retire from the company’s board of directors. King joined San Francisco–based iRhythm’s board in July 2012 and served as the company’s president and CEO from then until January 2021. “On behalf of the entire iRhythm team, I would like to thank Kevin for his contributions over […]
iRhythm plans silent AFib screening pilots, high-level hires and Zio Watch evaluations
iRhythm Technologies (NSDQ:IRTC) has big plans for 2022 and its remote external electrocardiogram monitors as the medical device developer gears up for growth. President and CEO Quentin Blackford is looking to hire an international general manager among other roles in the coming months, he told Medical Design & Outsourcing after presenting at this month’s 2022 J.P. Morgan Healthcare Conference, […]
iRhythm CEO considers costs on the path to profitability
Fresh off positive reimbursement news for its Zio remote external electrocardiogram monitoring device, the CEO of iRhythm Technologies (NSDQ:IRTC) doesn’t just have revenue on his mind. iRhythm President and CEO Quentin Blackford — the former Dexcom COO who replaced Mike Coyle in September — said his company will need to keep costs under control as it […]
iRhythm scores an important reimbursement win
iRhythm Technologies (NSDQ:IRTC) and other companies pioneering remote external EKG monitoring have scored a significant reimbursement win. The regional Medicare administrative contractor Novitas Solutions has set CPT codes 93243 and 93247 at roughly $223 and $233 respectively — news first reported by analysts this morning. The rates are retroactive to Jan. 1, 2022. “We would […]
12 of medtech’s biggest personnel changes in 2021
As medtech companies continued to drive innovation throughout the past 12 months, a number of high-level executives led the way. Some of those companies and those executives opted for major changes over the course of 2021, though, with some high-profile moves from medtech giant to medtech giant. Here are some of the biggest personnel moves […]
